FIELD: food industry.
SUBSTANCE: method includes cutting of a little sample out of a fish product. After that coloring reagent is added to the sample. The reagent contains dying agent penetrating cells and fluorescent dying agent cells not penetrating. Cells penetrating dying agent is turned into compounding imitating the first fluorescence in the presence of endocellular esterase activity. Non-penetrating fluorescent dying agent can penetrate the cell through infringe cell membranes and imitate the second fluorescence. The first and the second fluorescence are different. Freshness of a fish product is determined in virtue of at least one parametre chosen from a group consisting of the first fluorescence intensity, imitated by the incubated sample, second fluorescence intensity, imitated by the incubated sample, first distance from the upper sample end till sample faraway point where the first fluorescence is detected, the second distance from the upper sample end till sample faraway point where the second fluorescence is detected.
EFFECT: invention allows to evaluate fish products freshness accurately and objectively.
29 cl, 2 tbl, 12 dwg
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR EXPRESS DETECTION OF VIABLE MICROORGANISMS IN MEAT AND MEAT PRODUCTS | 2020 |
|
RU2755766C1 |
BIOPOLYMERIC MATRIX FOR PROLIFERATION OF CELLS AND REGENERATION OF NERVOUS TISSUES | 2011 |
|
RU2478398C1 |
METHODS FOR DETECTION OF ANTI-CYTOMEGALOVIRUS NEUTRALIZING ANTIBODIES | 2013 |
|
RU2660712C2 |
COMPOSITIONS AND METHODS USED FOR ASSESSING CYTOTOXICITY OF SINGLE CELLS | 2009 |
|
RU2532228C2 |
METHOD OF ESTIMATING CELL VIABILITY IN MICROBIOREACTOR BY MEANS OF OPTICAL LIGHT GUIDE | 2012 |
|
RU2532839C2 |
METHOD OF CYTOGENETIC ACTIVATION OF HUMAN LYMPHOCYTES | 2015 |
|
RU2603079C2 |
METHODS AND COMPOSITIONS FOR DETERMINATION OF ACTIVITY OF THERAPEUTIC CELL COMPOSITION | 2018 |
|
RU2775967C2 |
COMPOSITIONS AND METHODS FOR CELL ELIMINATION | 2008 |
|
RU2471349C2 |
METHOD FOR LONG-TERM CULTIVATION AND EXPANSION OF NK CELLS WITH HIGH VIABILITY AND FUNCTIONAL ACTIVITY | 2021 |
|
RU2794770C1 |
COMPOSITION AND METHOD FOR TREATMENT OF EYE DISEASE ASSICIATED WITH NUCLEIC ACIDS | 2012 |
|
RU2642609C2 |
Authors
Dates
2009-11-27—Published
2005-03-11—Filed